Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» July 2010
July 2010
Can Trius get market mojo working with $84M IPO?
Can Trius get market mojo working with $84M IPO?
Fierce Biotech
Trius Therapeutics
IPOs
Regeneron inks $295M antibody discovery deal with Astellas
Regeneron inks $295M antibody discovery deal with Astellas
Fierce Biotech
antibody discovery
Regeneron
Astellas
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
AstraZeneca bloodthinner Brilinta goes before U.S. experts
AstraZeneca bloodthinner Brilinta goes before U.S. experts
Reuters
Brilinta
blood thinners
AstraZeneca
FDA
advisory panels
Big Biotech: End of an Era
Big Biotech: End of an Era
Seeking Alpha
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Genentech
Dendreon
Genzyme
Gilead Sciences
GSK
Roche
Human Genome Sciences
Vertex Pharmaceuticals
Sanofi
Transdel Pharma Stands to Gain From Pain Medication
Transdel Pharma Stands to Gain From Pain Medication
Seeking Alpha
Transdel
Ketotransdel
Antigenics: Bright Future Ahead
Antigenics: Bright Future Ahead
Seeking Alpha
Antigenics
United Therapeutics back in black as revenue jumps 64%
United Therapeutics back in black as revenue jumps 64%
Bizjournals.com
United Therapeutics
earnings
Earnings Scorecard: Forest Labs
Earnings Scorecard: Forest Labs
Yahoo/Zacks.com
Forest Labs
earnings
Genzyme Giving Sanofi-Aventis the Cold Shoulder?
Genzyme Giving Sanofi-Aventis the Cold Shoulder?
Seeking Alpha
Genzyme
Sanofi
M&A
GSK
JNJ
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »